{"transactions":[{"id":727651,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T20:32:10.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":32000,"derivative":{"exercise_price":9.08,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001691160-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000169116026000002/ownership.xml","form_type":"4"}},{"id":1106334,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T12:38:15.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":4.94,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-25-087708","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000095017025087708/ownership.xml","form_type":"4"}},{"id":1468162,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T12:34:28.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 26, 2025 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":5.71,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-24-078168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000095017024078168/ownership.xml","form_type":"4"}},{"id":1483482,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:30:19.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":14.91,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-072195","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000095017024072195/ownership.xml","form_type":"4"}},{"id":1483481,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:30:19.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":13.98,"underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0000950170-24-072195","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000095017024072195/ownership.xml","form_type":"4"}},{"id":1483480,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:30:19.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":21.05,"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000950170-24-072195","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000095017024072195/ownership.xml","form_type":"4"}},{"id":1483479,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:30:19.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7181,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":6.13,"underlying":"Common Stock","underlying_shares":7181},"source":{"system":"sec-edgar","filing":"0000950170-24-072195","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000095017024072195/ownership.xml","form_type":"4"}},{"id":1483478,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T00:30:19.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35233,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":3.95,"underlying":"Common Stock","underlying_shares":35233},"source":{"system":"sec-edgar","filing":"0000950170-24-072195","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000095017024072195/ownership.xml","form_type":"4"}},{"id":1842019,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T13:00:13.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 28, 2024 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":1.22,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0001209191-23-040133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000120919123040133/doc4.xml","form_type":"4"}},{"id":1845237,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-23T20:05:27.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 21, 2024, subject to continued service through such date."}],"balance_after":30000,"derivative":{"exercise_price":14.91,"expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-039327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000120919123039327/doc4.xml","form_type":"4"}},{"id":2096166,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-12-06T02:22:54.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio, rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement."}],"balance_after":0,"derivative":{"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-023384","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000106299322023384/form4.xml","form_type":"4"}},{"id":2096165,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-12-06T02:22:54.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio, rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement."}],"balance_after":0,"derivative":{"expiration_date":"2031-09-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001062993-22-023384","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000106299322023384/form4.xml","form_type":"4"}},{"id":2096164,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-12-06T02:22:54.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":9060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio, rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement."}],"balance_after":0,"derivative":{"expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":9060},"source":{"system":"sec-edgar","filing":"0001062993-22-023384","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000106299322023384/form4.xml","form_type":"4"}},{"id":2096163,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-06T02:22:54.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":3586,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares underlying the Earnout RSU Awards were cancelled and converted into the right to receive the Per Share Merger Consideration (as defined in the Merger Agreement)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-22-023384","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000106299322023384/form4.xml","form_type":"4"}},{"id":2096162,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-06T02:22:54.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":3586,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock underlying restricted stock units granted pursuant to that certain Agreement and Plan of Merger, dated as of March 22, 2021, by and among the Issuer, Renovacor Holdings, Inc. and CHAQ 2 Merger Sub, Inc. (the \"SPAC Merger Agreement\") as Earnout RSU Awards (as defined in the SPAC Merger Agreement). Pursuant to the terms of the SPAC Merger Agreement, the Earnout RSU Awards have fully vested upon the consummation of the merger contemplated by the Agreement and Plan of Merger, dated as of September 19, 2022, by and among the Issuer, Rocket Pharmaceuticals, Inc. (\"Rocket\") and the other parties thereto (the \"Merger Agreement\")."}],"balance_after":3586,"source":{"system":"sec-edgar","filing":"0001062993-22-023384","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000106299322023384/form4.xml","form_type":"4"}},{"id":2136364,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-17T20:36:42.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":2.81,"expiration_date":"2032-10-13","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0001209191-22-053829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000120919122053829/doc4.xml","form_type":"4"}},{"id":2222091,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:05:31.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 23, 2023, subject to continued service through such date."}],"balance_after":18500,"derivative":{"exercise_price":13.98,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-22-039197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000120919122039197/doc4.xml","form_type":"4"}},{"id":2253550,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T20:04:50.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) May 25, 2023, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":12000,"derivative":{"exercise_price":1.94,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-013695","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000106299322013695/form4.xml","form_type":"4"}},{"id":2575937,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2021-09-08T23:02:24.000Z","date":"2021-09-03","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest and become exercisable 25% on the first anniversary of the grant and the remainder will vest and become exercisable in 36 equal monthly installments on the 3rd of each month for the remaining 36 months, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":24000,"derivative":{"exercise_price":7.73,"expiration_date":"2031-09-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001192482-21-000714","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000119248221000714/edgar.xml","form_type":"4"}},{"id":2654805,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T20:00:26.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan.  The option shall vest in full on June 23, 2022, subject to continued service through such date."}],"balance_after":12000,"derivative":{"exercise_price":35.86,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-043268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000120919121043268/doc4.xml","form_type":"4"}},{"id":3112009,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T20:00:11.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan.  The option shall vest in full on June 10, 2021, subject to continued service through such date."}],"balance_after":12000,"derivative":{"exercise_price":56.46,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-036231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000120919120036231/doc4.xml","form_type":"4"}},{"id":3491460,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T20:10:27.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan.  The option shall vest in full on June 11, 2020, subject to continued service through such date."}],"balance_after":12000,"derivative":{"exercise_price":21.05,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-19-036738","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000120919119036738/doc4.xml","form_type":"4"}},{"id":3924137,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-21T20:23:06.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award was issued pursuant to Issuer's 2017 Stock Option and Incentive Plan and will vest in full on May 17, 2019, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":12000,"derivative":{"exercise_price":25.73,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-18-013547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000089924318013547/doc4.xml","form_type":"4"}},{"id":4197853,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-02T20:36:19.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":7181,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the total number of options to purchase common stock of the Issuer received upon the exchange of options to purchase common stock of Deciphera Pharmaceuticals, Inc. for options to purchase common stock of the Issuer pursuant to the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan.  The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of May 26, 2017, subject to continued service through such dates."}],"balance_after":7181,"derivative":{"exercise_price":6.13,"expiration_date":"2027-06-03","underlying":"Common Stock","underlying_shares":7181},"source":{"system":"sec-edgar","filing":"0000899243-17-023131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000089924317023131/doc4.xml","form_type":"4"}},{"id":4197852,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-02T20:36:19.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":1271,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan.  The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of May 26, 2017, subject to continued service through such dates."}],"balance_after":0,"derivative":{"exercise_price":6.13,"expiration_date":"2027-06-03","underlying":"Common Stock","underlying_shares":7181},"source":{"system":"sec-edgar","filing":"0000899243-17-023131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000089924317023131/doc4.xml","form_type":"4"}},{"id":4197851,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-02T20:36:19.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":35233,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the total number of options to purchase common stock of the Issuer received upon the exchange of options to purchase common stock of Deciphera Pharmaceuticals, Inc. for options to purchase common stock of the Issuer pursuant to the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan.  The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of September 27, 2016, subject to continued service through such dates."}],"balance_after":35233,"derivative":{"exercise_price":3.95,"expiration_date":"2026-09-26","underlying":"Common Stock","underlying_shares":35233},"source":{"system":"sec-edgar","filing":"0000899243-17-023131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000089924317023131/doc4.xml","form_type":"4"}},{"id":4197850,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-02T20:36:19.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":6236,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan.  The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of September 27, 2016, subject to continued service through such dates."}],"balance_after":0,"derivative":{"exercise_price":3.95,"expiration_date":"2026-09-26","underlying":"Common Stock","underlying_shares":35233},"source":{"system":"sec-edgar","filing":"0000899243-17-023131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000089924317023131/doc4.xml","form_type":"4"}},{"id":4512558,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T19:05:05.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.49. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":3.49,"exercise_date":"2017-11-21","expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-16-000301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000166225216000301/form4.xml","form_type":"4"}},{"id":4512557,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T19:05:05.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.49. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":18750,"derivative":{"exercise_price":3.49,"exercise_date":"2017-08-21","expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-16-000301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000166225216000301/form4.xml","form_type":"4"}},{"id":4512556,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T19:05:05.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.49. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":12500,"derivative":{"exercise_price":3.49,"exercise_date":"2017-05-21","expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-16-000301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000166225216000301/form4.xml","form_type":"4"}},{"id":4512555,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":35655,"kind":"person","name":"Benz Edward J. JR","position":1,"cik":"0001691160","reported_name":"Benz Edward J. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-12-23T19:05:05.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.49. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":6250,"derivative":{"exercise_price":3.49,"exercise_date":"2017-02-21","expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-16-000301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691160/000166225216000301/form4.xml","form_type":"4"}}]}